About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5552962
Allelic
Composition
Faslpr/Faslpr
Itfg2Gt(OST215121)Lex/Itfg2Gt(OST215121)Lex
Genetic
Background
involves: 129S5/SvEvBrd * C57BL/6J * MRL/Mp
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Faslpr mutation (39 available); any Fas mutation (83 available)
Itfg2Gt(OST215121)Lex mutation (1 available); any Itfg2 mutation (39 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• worse than in Faslpr homozygotes
• increased faster in the blood and to a higher proportion than in Faslpr homozygotes
• decreased circulating B cells for the first 13 weeks of age compared with Faslpr homozygotes
• from 19 weeks compared with Faslpr homozygotes
• from 19 weeks compared with Faslpr homozygotes
• worse than in Faslpr homozygotes
• more severe autoimmune disease development with inflammatory cell infiltration of the kidney and hypertrophy in the lymphoid organs compared with Faslpr homozygotes
• compared with Faslpr homozygotes
• compared with Faslpr homozygotes

homeostasis/metabolism
• compared with Faslpr homozygotes

renal/urinary system
• compared with Faslpr homozygotes

hematopoietic system
• worse than in Faslpr homozygotes
• increased faster in the blood and to a higher proportion than in Faslpr homozygotes
• decreased circulating B cells for the first 13 weeks of age compared with Faslpr homozygotes
• from 19 weeks compared with Faslpr homozygotes
• from 19 weeks compared with Faslpr homozygotes

growth/size/body
• worse than in Faslpr homozygotes


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
01/28/2026
MGI 6.24
The Jackson Laboratory